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Abstract
Background: Lower lung function is associated with an elevated systemic white cell count in men. However, these
observations have not been demonstrated in a representative population that includes females and may be susceptible to
confounding by recent airway infections or recent cigarette smoking. We tested the hypothesis that lung function is
inversely associated with systemic white cell count in a population-based study.
Methods: The study population consisted adults aged 17290+ years who participated in the Third National Health and
Nutrition Examination Survey who did not report a recent cough, cold or acute illness in a non-smoking and smoking
population.
Results: In non-smoking adults with the highest quintile of the total white cell count had a FEV1 125.3 ml lower than those
in the lowest quintile (95% confidence interval CI: 2163.1 to –87.5). Adults with the highest quintile of the total white cell
count had a FVC 151.1 ml lower than those in the lowest quintile (95% confidence interval CI: 2195.0 to 2107.2). Similar
associations were observed for granulocytes, mononuclear cells and lymphocytes. In current smokers, similar smaller
associations observed for total white cell count, granulocytes and mononuclear cells.
Conclusions: Systemic cellular inflammation levels are inversely associated with lung function in a population of both non-
smokers and smokers without acute illnesses. This may contribute to the increased mortality observed in individuals with a
higher baseline white cell count.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a common
disease characterised by reduced lung function and obstructive
airflow limitation [1]. Over the past decade there has been
increasing interest in the potential importance of systemic
inflammation, both with regard to the pathogenesis of COPD
[2–4] and also as a biomarker to study associations between lung
function and systemic inflammation in population-based studies
[5-8]. The total white blood cell count is an established measure of
the systemic inflammatory response and surveys in the 1980s
[9–11] first reported an inverse association between Forced
Expiratory Volume (FEV1) and total white cell count. However,
these data only studied men and are susceptible to confounding by
recent airway infection [12] or incomplete adjustment for cigarette
smoking.
We have used data from the Third National Health and
Nutrition Examination Survey (NHANES III) to establish a
population of individuals who do not currently smoke cigarettes
and also a population of current smokers who were free of recent
respiratory and acute illness. We investigated the relationship
between the constituents of the white blood cell count and lung
function as measured by FEV1 and FVC. We hypothesised that an
increase in the cellular systemic inflammation levels as measured
by the total white blood cell count and its constituent cells would
be associated with a reduction in both FEV1 and FVC.
Methods
Study population
Ethics statement. The study received approval from a
Research Ethics Review Board [13] and all participants gave
their written consent prior to participation in the study. We used
data from NHANES III, a survey designed to examine the health
and nutrition of a randomly selected sample of the US population.
The survey was conducted between 1988 and 1994 and full details
of the survey design and examination procedure have been
published by the National Centre for Health Statistics [14]. The
study received approval from a Research Ethics Review Board
and all participants gave their consent prior to participation in the
study. The population studied were aged over 17 years. To
remove the potential confounding factor of recent illness on lung
function or systemic white cell count, individuals/subjects were
excluded if they responded ‘yes’ or ‘unknown’ to the question ‘in
the past few days have you had a cough, cold, or other acute
illness’. There were 2 study populations, the first population were
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than 15 ng/ml [15] and the second consisted of self-reported
current smokers. Exclusions were also made for missing data on
the total white cell count, lung function, smoking status and body
mass index.
Data collection
Blood samples were taken for measurement of cotinine, the total
white cell count and its constituent differential cells including
granulocytes, lymphocytes, monocytes, eosinophils and basophils.
White blood cell count was determined using a fully automated
Coulter S-PLUS JR hematology analyzer (Beckman Coulter,
Fullerton, California, United States). Anthropometric measure-
ments were made including height, weight and spirometry using
standardized techniques (including FEV1 and FVC). A detailed
description of laboratory methods has been published [16].
Statistical analyses
Using self-reported smoking history we quantified total cigarette
consumption in pack-years. Lung function measures were modelled
adjusting for age, sex, height, smoking (status and pack-years), body
mass index (BMI) and race/ethnicity to derive the most parsimo-
nious model that minimized variance. More complex models for
lung function of higher order variables for age and height were
examined but these did not improve the fit of the model, and
therefore the simplest model was chosen. Inflammatory cell counts
werearbitrarilycategorizedinto quintilesseparately innon-smoking
and smoking populations and the relationships between measures of
Table 1. Demographics and characteristics of the study population of individuals who have never smoked selected from the adult
NHANES III population*.
Variable
Non-Smoking Population
N=8381
Current smokers
N=2790
Mean (SD) Number (%) Mean (SD) Number (%)
Sex
Males
Females
3579 (42.7)
4802 (57.3)
1603 (57.5)
1187 (42.5)
Age 46.4 (20.4) 41.0 (16.1)
Smoking status
Never
Ex
Curent
5972 (71.3)
2409 (28.7)
2790 (100)
Pack years** 14 (3.5 to 36) 11 (3.2 to 25.5)
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Mexican-American
Other
3485 (41.6)
1990 (23.7)
2514 (30.0)
392 (4.7)
1061 (38.0)
933 (33.4)
701 (25.1)
95 (3.4)
Height (cm) 165.7 (9.9) 168.8 (9.2)
BMI (kg/m
2) 27.2 (5.8) 25.9 (5.4)
WHR (n=9008) 0.91 (0.09) 0.92 (0.09)
FEV1 (ml) 2970 (943) 3144 (943)
FVC (ml) 3719 (1103) 4013 (1071)
FEV1/FVC 0.80 (0.09) 0.78 (1.0)
Asthma** 502 (6.0) 188 (6.7)
COPD** 697 (8.7) 397 (14.7)
White cell counts
Total white cells x10
3 6.91 (2.13)
n=8381
7.9 (2.3)
n=2790
Granulocytes x10
3 4.27 (1.63)
n=8256
4.88 (1.89)
n=2732
Mononuclear cells x10
9/l 0.40 (0.21)
n=8256
0.45 (0.23)
n=2732
Lymphocytes x10
3 2.24 (0.97)
n=8380
2.52 (0.81)
n=2789
Eosinophils*** 2 (1–4) SD=2.7
n=2260
2 (1–4) SD = 2.7
n=798
Basophils*** 0 (0–1)SD=0.7
n=2269
0(0–1)SD=0.8 n=798
*study population excludes individuals who report a cough, cold or other acute illness in the past few days.
**Asthma as defined by self report of doctor diagnoses and COPD defined by as self-reported physician-diagnosed emphysema and/or chronic bronchitis, or by GOLD
spirometry criteria (FEV1/FVC,70% and FEV1,80%,although post bronchodilator values were unavailable).
***median and interquartile range.
doi:10.1371/journal.pone.0021593.t001
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regression. We fitted the models with quintiles of inflammatory cell
counts as both ordered and unordered factors and compared the
twomodels forevidenceof departurefromlinearity. The p-value for
linear trend was given when there was no departure from linearity.
The results arepresented inquintiles and we also presentthe data as
per SD increase of the inflammatory cell count as all associations
observed were linear. Potential confounders such as plasma glucose
and waist:hip ratio were fitted as continuous or categorical variables
as appropriate, and were examined to determine whether they
altered the regression coefficients. A factor was considered a
confounding factor if its addition to the model changed the size of
effect by 15% or more. A sensitivity analyses was conducted
excluding individuals with greater than 10 cigarette pack years and
only including individuals with a serum cotinine ,3 ng/ml [17]
(which represents lower levels of exposure to environmental tobacco
smoke). The data was also investigated to determine if the
association differed according to gender.
Due to complex, multistage probability sample design of
NHANES III, estimates were calculated accounting for the survey
design, using the specialized survey command within STATA SE
10.0 (Stata Corporation, Texas).
Results
From the total study population of 20050 individuals aged
17290+ years who provided data for the NHANES III survey,
4990 participants reported current cigarette consumption and of
those who did not smoke, 3163 participants either reported a
cough, cold, or other acute illness in the previous few days or did
not declare the status of these symptoms. This gave a study
population of 11867 individuals of whom 8381 participants had
cotinine of ,15 mg/ml and provided paired data permitting
assessment of the association between white cell count and lung
function while also adjusting for possible confounding factors. The
study population is described in Table 1. Using similar selection
criteria for those participants who were current smokers, 2790
individuals met the study inclusion criteria (Table 1).
The total white cell count was inversely associated with FEV1
with the highest quintile being 2125.3 ml (95% confidence
intervals CI: 2163.1 to 287.5) lower than the lowest quintile
(Table 2). Similar inverse associations were seen for granulocytes
(highest vs lowest quintile 2119.3 ml; 95%CI: 2156.7 to 281.9),
mononuclear cells (highest vs lowest quintile 295.1 ml; 95%CI:
2130.2 to 260.1) and lymphocytes (highest vs lowest quintile
250.6 ml; 95%CI: 281.3 to 219.9). There was no association
between FEV1 and eosinophils and basophils. Similar findings
were found in relation to FVC, such that the total white cell count
was also inversely associated with FVC (highest vs lowest quintile
2151.1 ml; 95%CI 2195.0 to 2107.2), and similar associations
were seen for granulocytes (highest vs lowest quintile 2158.2 ml;
95%CI: 2204.0 to 2112.4), mononuclear cells (highest vs lowest
quintile 2116.1 ml; 95%CI: 2158.3 to 273.8), and lymphocytes
(highest vs lowest quintile 263.3 ml; 95%CI: 2101.8 to 224.8).
There was no association between either eosinophils or basophils
and FVC (Table 3). The sensitivity analyses excluding those
individuals with .10 cigarette pack years and cotinine of .3 ng/
ml found similar findings such that increased levels total white cell
count, granulocytes, mononuclear cells, and lymphocytes were
significantly associated with lower levels of lung function, however
the effect estimates were up to 30 ml lower in the top quintile.
There was no association between the FEV1:FVC ratio and
either total white blood cell count, granulocytes, mononuclear
cells, lymphocytes, eosinophils or basophils (data not shown). In
addition, there were no significant effect modification by gender of
the association between systemic inflammatory cell levels and lung
function.
When these associations where examined in a population of
smokers, similar associations were observed however the effect
estimates were smaller (Table 4). Total white cell count was
inversely associated with FEV1 (highest to lowest quintile 278.1 ml,
95%CI: 138.7 to 217.6). In addition, granulocytes (highest to
lowest quintile 268.3 ml, 95%CI: 2132.6 to 24.2), mononuclear
cells (highest to lowest 273.0 ml 95%CI: 2135.2 to 210.7) were all
inversely related to FEV1. In smokers, lymphocytes were not
associated with FEV1. Similar to non-smoking population,
eosinophils and basophils were not associated with lung function.
Discussion
This is the first population-based epidemiological study, in men
and women in whom recent acute illness has been excluded, to
demonstrate an inverse association between the systemic inflam-
mation levels as measured by the total white cell count and lung
function using FEV1 and FVC. Similar inverse associations were
also observed for subgroups of this inflammatory response of
granulocytes, and monocytes in both non-smoking and smoking
populations, whereas the effect of lymphocytes was only found in
the non-smoking study population.
This analysis has a variety of strengths including the high
response rate in the NHANES III survey with 86% and 78% of
those invited to participate in the questionnaire survey and
medical examination doing so [14]. Another strength of this study
is the use of systematic measurements of both the white cell count,
its constituent cells, blood cotinine to objectively define recent
exposure to tobacco smoke, and also physiological measurements
of lung function in a well defined population with no knowledge of
the hypothesis being tested. In addition, a further strength of this
analysis was the use of a large population who provided data on
both self-reported smoking history and exposure to recent colds,
coughs and acute illnesses.
Cigarette smoking is known to cause acute decreases in lung
function [18] and also to promote acute systematic inflammatory
responses [19]. We adjusted for this important confounding factor
using self reported smoking history and also the objective measure
of serum cotinine to identify those individuals who have recently
been exposured to cigarette smoke. Similarly, recent coughs, colds
and acute illnesses will also impact on the systemic inflammation
levels and reduce lung function [12], and the fact that 22% of the
eligible population were excluded by this criterion suggests that it
has the considerable potential to confound observations of
associations of systemic inflammation and lung function. Exclud-
ing these individuals from the analysis thus reduces the risk of
confounding and strengthens our confidence in the veracity of our
data, although it obviously limits the generalisability of this part of
the analysis to non-smokers.
We are unable to exclude the possibility of confounding by
either exposure to other sources of environmental pollution or sub-
clinical infections that may modify either lung function and the
cellular inflammatory response. It is also important to consider
that data from a cross-sectional study such as NHANES III does
not permit temporal relationships to be considered, and therefore
we cannot exclude the possibility of reverse causality, i.e. lower
lung function leading to an elevated total white blood cell count.
Initial studies of the association between leucocyte count and
lung function were reported in 1984 [9;10]. Yeung et al [10] used
data from two cohort occupational cohorts (n=3446) and
reported an inverse correlation between leucocyte count and both
Inflammation and Lung Function
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the Normative Aging Study (a cohort study of healthy men
recruited in 1963), Sparrow et al [9] similarly report an inverse
association between the peripheral leucocyte count and both FEV1
and FVC, after adjustment for age, height and smoking habits. In
1988, Carel et at [11] studied another healthy occupational cohort
of 307 men, and again reported similar findings to the first two
studies [11].
The only population-based study of both men and women to study
the association between the systemic cellular inflammation levels and
lung function was by Lewis et al, and did not measure the total white
blood cell count, but used leucocyte subgroups to characterise the
inflammatory response [20]. In addition, the analysis potentially
included those with a recent colds, coughs and acute illnesses as they
were not specifically identified ande x c l u d e df r o mt h ea n a l y s i s .T h i s
study of 2369 individuals demonstrated inverse associations between
FEV1 and systemic neutrophils, monocytes, basophils, eosinophils but
not lymphocytes. We reported similar inverse relations for neutrophils
(which constitute the majority of granulocytes) and monocytes with
both FEV1 and FVC. However, we also observed an inverse
association between lung function and circulating lymphocytes, but
no associations with eosinophils or basophils. One potential explana-
tion for these differences between our data and that of Lewis et al is the
method of measuring the differential leucocytes; NHANES III stored
frozen blood prior to analysing using a fully automated Coulter
hematology analyzer while Lewis at el used a Technicon cell analyzer
on all samples within 24 hours. Alternatively, our selection of
individuals who had evidence of a recent cough, cold or infection
will have created a population that is not directly comparable to that of
Lewis et al.
The observation that the systemic neutrophil count is inversely
associated with lower lung function is consistent with the
hypothesis that airway neutrophil response is important in the
pathophysiological processes that drive COPD [21] and asthma
Table 2. Association between categories of blood inflammatory cells and Forced Expiratory Volume in one second in non-smoking
adults*.
White cell category Values Forced Expiratory Volume in one second**
Coef(ml) 95% CI
Total white cell count (n=8351) 1.75–5.25
5.26–6.2
6.21–7.15
7.16–8.35
8.36–43.65
per SD increase
0
223.8
239.6
282.1
2125.3
p-trend ,0.001
245.0
256.9 to +9.3
271.8 to 27.5
2112.7 to 251.5
2163.1 to 287.5
256.4 to 233.6
Granulocytes (n=8256) 0.2–2.95
2.96–3.7
3.71–4.4
4.41–5.4
5.41–17.75
per SD increase
0
218.9
241.8
275.5
2119.3
p-trend ,0.001
241.3
244.3 to +6.4
274.2 to 29.4
2106.9 to 244.2
2156.7 to 281.9
253.1 to 229.5
Mononuclear cells (n=8256) 0–0.25
0.26–0.35
0.36–0.4
0.41–0.5
0.51–5.35
per SD increase
0
27.3
220.1
257.7
295.1
p-value ,0.001
238.1
233.1 to +18.5
256.4 to +16.3
292.9 to 222.5
2130.2 to 260.1
249.8 to 226.4
Lymphocytes (n=8380) 0.35–1.65
1.66–1.95
1.96–2.3
2.31–2.75
2.76–33.85
per SD increase
0
10.0
3.1
215.7
250.6
p-trend =0.001
217.7
223.0 to 42.9
231.8 to 37.9
250.5 to 19.1
281.3 to 219.9
225.8 to 29.6
Eosinophils (n=2260) 0–1
2
3–4
5–25
per SD increase
0
8.8
233.5
243.5
p-trend =0.14
216.7
247.7 to 65.3
285.3 to 18.3
2107.8 to 20.8
239.2 to 5.8
Basophils (n=2260) 0
1
2–6
per SD increase
0
26.0
2.2
p-trend =0.38
5.24
212.5 to 64.5
261.4 to 65.8
213.9 to 24.4
*study population excludes individuals who report a cough, cold or other acute illness in the past few days.
**adjusted for age, sex, height (continuous), race/ethnicity, body mass index (continuous), and smoking status (categories of never/ex) and cigarette pack years smoked
(continuous) using linear regression.
***5 quintiles could not formed due to large number of basophils=0.
doi:10.1371/journal.pone.0021593.t002
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airway physiology has been difficult to consistently establish.
Similarly, the systemic monocyte count, a precursor of macro-
phages, was inversely associated with decreased lung function, and
again these inflammatory cells are also regarded as having a key
role in the development of COPD [23] while eosinophils are
inversely associated with lung function in non-smoking men
[24;25]. However, the inverse association between the systemic
lymphocyte response and lung function is a new one and suggests
that circulating lymphocyte may also be implicated in the loss of
lung function. This is plausible, as histological samples from
patients with COPD have demonstrated an increased lymphocyte
count compared to those without COPD [26]. It is important to
consider that our cross-sectional study design makes it difficult to
distinguish between a global increase in the activity of the cellular
inflammatory response, and the individual effects of systemic
inflammatory cells. These will require more detailed study possibly
by observing the parallel airway and systemic cellular inflamma-
tory responses over time.
There has been much interest in the associations between the
systemic inflammatory response and lung function with most
studies demonstrating an inverse relationship between these
variables both in general populations [5–8] and in studies that
focussed on individuals with COPD [2–4]. This has coincided with
an increasing appreciation that COPD is a disease with systemic
manifestations that contribute to morbidity [27] which require
greater understanding and possibly probably targeted interven-
tions to benefit the individual patient. The studies of systemic
inflammation may result in enhanced understanding of the
pathophysiological mechanisms which can then be used to tailor
effective interventions for the varied phenotypes associated with
COPD.
In summary, we report for the first time that the total white cell
count is inversely associated with both FEV1 and FVC in a
population of men and women who have not had a recent cold,
cough or acute illness. These associations are also observed for
circulating granulocytes, lymphocytes and monocytes and lung
function. Future studies of inflammation and lung disease should
Table 3. Association between categories of blood inflammatory cells and Forced Vital Capacity in non-smoking adults*.
White cell category Values Forced Vital Capacity**
Coef (ml) 95% CI
Total white blood cell count (n=8381) 1.75–5.25
5.26–6.2
6.21–7.15
7.16–8.35
8.36–43.65
per SD increase
0
0.90
235.3
293.9
2151.1
p-trend ,0.001
258.2
244.0 to +45.8
275.1 to +4.6
2132.3 to 255.5
2195.0 to 2107.2
272.0 to 244.4
Granulocytes (n=8256) 0.2–2.95
2.96–3.7
3.71—4.4
4.41–5.4
5.41–17.75
per SD increase
0
217.6
234.0
296.8
2158.2
p-trend ,0.001
256.1
251.5 to +16.4
275.4 to +7.3
2142.6 to 251.0
2204.0 to 2112.4
270.4 to 241.9
Mononuclear cells (n=8256) 0–0.25
0.26–0.35
0.36–0.4
0.41–0.5
0.51–5.35
per SD increase
0
213.2
215.5
261.5
2116.1
p-trend ,0.001
245.2
247.4 to +21.1
268.3 to +37.4
2104.2 to 218.9
2158.3 to 273.8
257.6 to 232.7
Lymphocytes (n=8380) 0.35–1.65
1.66–1.95
1.96–2.3
2.31–2.75
2.76–33.85
per SD increase
0
+15.1
+17.1
218.2
263.3
p-trend =0.001
220.1
229.4 to +59.6
222.2 to +56.5
262.1 to +25.7
2101.8 to 224.8
230.1 to 210.2
Eosinophils (n=2260) 0–1
2
3–4
5–25
per SD increase
0
+48.8
220.2
26.8
p-trend =0.77
21.9
222.6 to +120.2
275.7 to +35.2
284.6 to +71.0
227.8 to +24.0
Basophils (N=2260) 0
1
2–6
per SD increase
0
+33.6
+36.7
p-trend =0.11
+15.6
211.2 to +78.5
230.4 to +103.8
24.8 to 36.0
*study population excludes individuals who report a cough, cold or other acute illness in the past few days.
**adjusted for age, sex, height (continuous), race/ethnicity, body mass index (continuous), and smoking status (categories of never/ex) and cigarette pack years smoked
(continuous) using linear regression.
***5 quintiles could not formed due to large number of basophils=0.
doi:10.1371/journal.pone.0021593.t003
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cellular inflammation levels in addition to the more sophisticated
cytokines that are also available. As higher lung function is a
predictor of subsequent survival [28;29], these associations may
contribute to the increased mortality that is associated with a both
higher white cell count [29;30] and elevated systemic inflamma-
tory status [31] observed in prospective studies.
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